{
  "id": "0f32934d9580a9b8",
  "title": "FluoGuide A / S : FDA Clears FluoGuide IND for FG001 in High - Grade Glioma ; U . S . Clinical Trial Remains on Track",
  "description": "20260220T203000Z",
  "content": "",
  "source": "finanznachrichten.de",
  "source_url": "https://www.finanznachrichten.de/nachrichten-2026-02/67754822-fluoguide-a-s-fda-clears-fluoguide-s-ind-for-fg001-in-high-grade-glioma-u-s-clinical-trial-remains-on-track-200.htm",
  "published_at": "20260220T203000Z",
  "fetched_at": "2026-02-21T00:28:01.720640+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "ai"
  ],
  "location": "Germany",
  "raw_data": {
    "url": "https://www.finanznachrichten.de/nachrichten-2026-02/67754822-fluoguide-a-s-fda-clears-fluoguide-s-ind-for-fg001-in-high-grade-glioma-u-s-clinical-trial-remains-on-track-200.htm",
    "url_mobile": "",
    "title": "FluoGuide A / S : FDA Clears FluoGuide IND for FG001 in High - Grade Glioma ; U . S . Clinical Trial Remains on Track",
    "seendate": "20260220T203000Z",
    "socialimage": "https://www.finanznachrichten.de/chart-fluoguide-a-s-aktie-intraklein-frankfurt.png",
    "domain": "finanznachrichten.de",
    "language": "English",
    "sourcecountry": "Germany"
  }
}